MAT Regulations Relaxed During COVID-19 Pandemic—This Should Catalyze Further Reform
In order to facilitate social distancing among people in treatment for opioid use disorder, the Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration relaxed some onerous regulations surrounding the use of buprenorphine or methadone in Medication Assisted Treatment.
Comment
expand_more
expand_less